University of Arkansas Office of Technology Licensing

E-mail Len Schaper

Link to web site

Sep 2007 article

March 2001 article

Aug 1999 article

Len Schaper received his B.S. in Electrical Engineering at Newark College of Engineering in 1967, his S.M. in Electrical Engineering at the Massachusetts Institute of Technology in 1968, and the Doctorate in Engineering Science from New Jersey Institute of Technology in 1973. He taught both Electrical and Civil Engineering at NJIT before joining AT&T Bell Laboratories in 1978. There he held several positions in electronic power conversion, electronic technology planning, and technical management. He was one of the co-inventors of the early silicon substrate MCM-D development known as Advanced VLSI Packaging.

see list of other inventors

TLO News

IP2Biz and International Speciality Chemicals Announce Joint Development Agreement for TiO2-based Nanowires. To read more,click here.

SparkIP, an online intellectual property (IP) network for the scientific community, today announced significant growth of their online network. In the past quarter the addition of new universities, research institutions and licensable technologies has resulted in SparkIP becoming the world’s largest online IP marketplace. To read more, click here.

Information Technology

Tactile Access to Advanced Software for Blind/Low Vision (BLV) Users

This invention allows for the use of sophisticated software packages that employ Graphical User Interfaces (GUIs) by blind/low vision (BLV) individuals. Click here for additional article.

Food Technology

All Natural Edible Antimicrobial Packaging Film

University food scientists have developed all-natural edible films showing inhibition against Listeria monocytogenes, Salmonella and E. coli 0157:H7.   

Production of Conjugated Linoleic Acid by Light Process

Conjugated Linoleic Acid (CLA) has been shown to have powerful anti-cancer, anti-heart disease, anti-inflammatory and anti-obesity properties in animals studied.

Biotechnology

Nuisance Protein Abatement

The use of bacterial cell culture to manufacture specific recombinant proteins for both industrial and medical purposes is well established.

Drug for the Treatment and Prevention of Osteoporosis 

Osteoporosis is a major public health problem which affects approximately 10 million Americans.  Over 300,000 hip fractures per year can be attributed to osteoporosis, resulting in a cost of over 18 billion dollars.